期刊文献+

对氧磷脂酶-1与氧化低密度脂蛋白在脑梗死发病机制中的作用 被引量:3

Study on the role of paraoxonase-1 and oxidative low-density lipoproteins in cerebral infarction pathogenesis
暂未订购
导出
摘要 目的探讨血清对氧磷脂酶-1活性与血浆氧化低密度脂蛋白在动脉粥样硬化性脑梗死发病机制中的作用。方法采用分光光度法和酶联免疫吸附法检测127例动脉硬化性脑梗死患者血清对氧磷脂酶-1活性,以及血浆氧化型低密度脂蛋白、血浆血管性假血友病因子、血浆α颗粒膜蛋白-140(GMP-140)及血清一氧化氮的变化,并对各项指标间的关系进行相关分析。另选择128例同期行体格检查或经头部CT检查无异常的轻度颅脑创伤患者作为对照。结果脑梗死组和对照组受试者血清对氧磷脂酶-1活性均在国人正常值范围。但与对照组比较,脑梗死组患者血清对氧磷脂酶-1活性明显降低(P<0.05),血浆氧化低密度脂蛋白水平明显升高(P<0.05);而且血浆血管性假血友病因子、血浆α颗粒膜蛋白-140等项指标亦均高于对照组(P<0.01),血清一氧化氮水平低于对照组(P<0.01)。相关分析表明,血清对氧磷脂酶-1活性分别与血浆血管性假血友病因子、血浆α颗粒膜蛋白-140及血浆氧化低密度脂蛋白水平呈负相关(r=0.423,0.383,0.339;均P<0.01),与血清一氧化氮水平呈正相关(r=0.205,P<0.01);而血浆氧化低密度脂蛋白与血清一氧化氮水平呈负相关(r=0.223,P<0.01),与血浆血管性假血友病因子和血浆α颗粒膜蛋白-140水平呈正相关(r=0.315,0.203;均P<0.01)。血清对氧磷脂酶-1活性与血清高密度脂蛋白-胆固醇、载脂蛋白B之间无相关性(P>0.05)。结论脑梗死组患者血清对氧磷脂酶-1活性的下降与其血浆氧化低密度脂蛋白水平增高有关,而血清对氧磷脂酶-1活性下降及血浆氧化低密度脂蛋白水平增高是脑梗死发病危险因素。 Objective To determine the role of serum paraoxonase-1 (PON-1) activity and plasma oxidative low-density lipoproteins (ox-LDL) in the pathogenesis of atherosclerotic cerebral infarction. Methods Serum PON-1 activity and ox-LDL were measured with ultraviolet spectroscopy, plasma ox-LDL, von Willebrand factor (vWF), α-granular membrane protein-140 (GMP-140) were detected with ELISA and serum NO level was examined with nitrate reductase chromatometry, and analyzed their relationship. In corresponding period, selected 128 minimal craniocerebral wound patients without abnormal physical examination or encephalo-CT findings as controls. Results Serum PON-1 activity was normal in cerebral infarction group and control group, but it was significantly lower and ox-LDL level was significantly higher in cerebral infarction group than in control group (P〈0.05). In comparison with control group, plasma vWF and GMP-140 were all higher (P〈 0.01), and serum NO level was lower (P〈 0.01) in cerebral infarction group. Correlation analysis showed that serum PON-1 activity was negatively correlated with serum vWF (r=-0.423, P〈 0.01), GMP-140 (r=-0.383, P〈 0.01) and plasma ox-LDL (r=-0.339, P〈 0.01) respectively, but was positively correlated with serum NO level (r=0.205, P〈0.01). Plasma ox-LDL was negatively correlated with serum NO level (r= - 0.223, P〈0.01), but was positively correlated with vWF (r=0.315, P〈0.01) and GMP-140 (r=0.203, P〈0.01) respectively. Serum PON-1 activity was not related with serum HDL-C, and ApoB (P〉 0.05). Conclusion Decreased serum PON-1 activity is associated with increased plasma ox-LDL in patients with cerebral infarction. Decreased serum PON-1 activity and increased plasma ox-LDL are the risk factors of cerebral infarction.
出处 《中国现代神经疾病杂志》 CAS 2006年第4期275-278,共4页 Chinese Journal of Contemporary Neurology and Neurosurgery
关键词 磷脂酶类 脂蛋白类 LDL 脑动脉硬化 脑梗塞 Phospholipases Lipoproteins, LDL Cerebral arteriosclerosis Cerebral infarction
  • 相关文献

参考文献14

二级参考文献28

共引文献33121

同被引文献32

  • 1蒋兴亮,周京国,唐中,张均.冠心病患者对氧磷酯酶1活性与氧化型低密度脂蛋白的关系[J].中华老年心脑血管病杂志,2004,6(5):305-307. 被引量:8
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33093
  • 3Lei C,Wu B,Liu M,Chen Y.Risk factors and clinical outcomes associated with intracranial and extracranial atherosclerotic stenosis acute ischemic stroke.J Stroke Cerebrovasc Dis,2014,23:1112-1117.
  • 4Tamada M,Makita S,Abiko A,Naganuma Y,Nagai M,Nakamura M.Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a useful marker for earlystage carotid atherosclerosis.Metabolism,2010,59:653-657.
  • 5Chei CL,Yamagishi K,Kitamura A,Kiyama M,Imano H,Ohira T,Cui R,Tanigawa T,Sankai T,Ishikawa Y,Sato S,Hitsumoto S,Iso H; CIRCS Investigators.High-density lipoprotein subclasses and risk of stroke and its subtypes in Japanese population:the Circulatory Risk in Communities Study.Stroke,2013,44:327-333.
  • 6Okuzumi A,Ueno Y,Shimada Y,Tanaka Y,Miyamoto N,Yamashiro K,Tanaka R,Hattori N,Urabe T.Impact of low-density lipoprotein to high-density lipoprotein ratio on aortic arch atherosclerosis in unexplained stroke.J Neurol Sci,2013,326(1/2):83-88.
  • 7Fernandez ML,Webb D.The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk.J Am Coll Nutr,2008,27:1-5.
  • 8Amarenco P,Goldstein LB,Callahan A 3rd,Sillesen H,Hennerici MG,O'Neill BJ,Rudolph AE,Simunovic L,Zivin JA,Welch KM; SPARCL Investigators.Baseline blood pressure,low-and high-density lipoproteins,and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.Atherosclerosis,2009,204:515-520.
  • 9Gonzá1ez Hernández A,Fabre Pi O,López Fernández JC,Díaz Nicolás S,Cabrera Hidalgo A.Risk factors,etiology and prognosis in patients with ischemic stroke and diabetes mellitus.Rev Clin Esp,2008,208:546-550.
  • 10Shafique K,Mirza SS,Mughal MK,Arain ZI,Khan NA,Tareen MF,Ahmad I.Water-pipe smoking and metabolic syndrome:a population-based study.PLoS One,2012,7:E39734.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部